While OA is predominantly diagnosed on the basis of clinical criteria, imaging may aid with differential diagnosis in clinically suspected cases. While plain radiographs are traditionally the first choice of imaging modality, MRI and US also have a valuable role in assessing multiple pathologic features of OA, although each has particular advantages and disadvantages. Although modern imaging modalities provide the capability to detect a wide range of osseous and soft tissue (cartilage, menisci, ligaments, synovitis, effusion) OA-related structural damage, this extra information has not yet favourably influenced the clinical decision-making and management process. Imaging is recommended if there are unexpected rapid changes in clinical outcomes to determine whether it relates to disease severity or an additional diagnosis. On developing specific treatments, imaging serves as a sensitive tool to measure treatment response. This narrative review aims to describe the role of imaging modalities to aid in OA diagnosis, disease progression and management. It also provides insight into the use of these modalities in finding targeted treatment strategies in clinical research.
Introduction
OA is now defined as a group of overlapping distinct joint disorders that affects one or several joints, including both small and large joints [1] . Typical clinical presentations include pain, transient morning stiffness and crepitus on joint motion, physical disability and impairment of quality of life [2] . Despite the fact that OA is extremely common, it can be difficult to diagnose, especially in the early stage when the disease is not well established. Furthermore, current treatments are limited to analgesics and antiinflammatory agents, with weak to moderate benefits, in combination with exercise, weight loss, physiotherapy or orthotic devices [3] .
Imaging modalities have expanded our knowledge on OA pathogenesis, showing that all structures of the joint might be involved, including the loss of articular cartilage, synovial hypertrophy and inflammation, meniscal damage, subchondral bone remodelling with the formation of osteophytes and bone marrow lesions (BMLs), as well as muscle and ligament abnormalities [1] . Although conventional radiography is the most commonly used technique in OA, modern modalities such as MRI and US have enabled visualization of inflammatory lesions in joints and periarticular regions. At present, except for surgical procedures, imaging outcome measures are not included in routine clinical pathways, as they have not been demonstrated to direct effective therapeutic choices for OA [4] . The role of imaging in clinical practice for OA diagnosis, management and follow-up has not been clearly defined. Choosing the most appropriate strategy through a more targeted and personalized approach could optimize effectiveness, in which imaging modalities may play an important role. This narrative review of the evidence will discuss the value of adding imaging to the clinical
What does imaging add to my clinical diagnosis?
According to recent clinical practice guidelines, a clinical diagnosis can be made in a typical OA patient without requiring further investigations when a person is 545 years of age and has activity-related joint pain, morning stiffness lasting <30 min [3] , crepitus on active motion, bony enlargement and no detectable warmth [57] . Additional features that may be present include deformity, instability, periarticular or joint-line tenderness and pain on patellofemoral compression [8] . Examination features such as a reduction of internal rotation and hip pain (usually felt in the groin or deep buttock) may allow the clinician to diagnose hip OA with confidence [9] . Consideration of red flags (e.g. severe local inflammation, erythema, progressive pain unrelated to use) suggesting tumour, septic arthritis, fracture or serious bony pathology is required during the clinical examination. In clinical practice, laboratory tests (e.g. RF, ESR and CRP) would be requested to confirm or exclude coexistent inflammatory disease in patients with suggestive OA symptoms or signs. However, these laboratory tests of blood, urine or SF are not essential, as a diagnosis can be made in their absence. If a palpable effusion is present, SF should be aspirated and analysed to exclude inflammatory disease and to identify the presence of urate and calcium pyrophosphate crystals.
In atypical presentations, imaging can be helpful when the clinical diagnosis is uncertain. However, it has been noted that many structural abnormalities seen on imaging are very common in older populations [10] and thus should be considered in the appropriate clinical context. Generally it is believed that there is a lack of concordance between the structural radiographic changes and symptoms of OA [11] . Minimal changes can be associated with a lot of pain, or vice versa. A variety of trauma may trigger a joint to repair itself, often compensating for the initial trauma and resulting in a structurally altered but symptom-free joint. Furthermore, the accuracy of the association between symptoms and radiographic OA could be affected by the extent of radiographic view, definitions of pain, study group and other potential confounders [1218] .
Although many studies have applied imaging for diagnostic purposes, there was a lack of studies in which imaging was applied in addition to clinical findings to evaluate its additional impact on the certainty of diagnosis, which was a predefined criterion for inclusion. Due to the absence of strong evidence, the systematic use of imaging in the diagnostic process is not recommended in cases with a typical clinical presentation of OA. However, based on the joint site and clinical presentation, imaging might be considered when diagnoses other than OA are suspected. If imaging is needed, radiography should be used before other modalities. To make additional diagnoses, soft tissues are best imaged by US or MRI and bone by CT or MRI. The main advantages and disadvantages of different imaging modalities used in OA are summarized in Table 1 .
X-ray in the diagnosis of OA Being widely available, economical and well accepted by patients, radiography remains the cornerstone in obtaining an image-based OA diagnosis. In the early stages of disease onset, developments such as osteophytes, joint space narrowing (JSN), subchondral sclerosis or subchondral cysts are well visualized with this modality (Fig. 1) [19] . Studies comparing radiological criteria with clinical criteria for the diagnosis of knee OA have shown a wide range of sensitivity and specificity. A systematic review has identified a <10% consistent agreement between radiological and clinical diagnoses [20] . Furthermore, due to the projectional nature of radiographs, the diagnosis of OA depends on the radiographic view used, with the likelihood of a diagnosis of knee OA increasing with the number of views used [21] . In particular for the knee, weight-bearing and posteroanterior and lateral views are often recommended [22] . Using a posteroanterior view alone (the standard view requested by most non-specialist clinicians, e.g. primary care doctors) identifies only 56% of cases of radiographic OA; adding a skyline or lateral view increases the identification to 87% and all three views increases identification to almost 100% [21] . The presence of more than one radiographic feature of OA, particularly if combined with typical clinical features, strongly increases diagnostic certainty and further diagnostic imaging (MRI sonography, scintigraphy) is seldom indicated to confirm a diagnosis of knee OA [8] .
The ACR classification criteria have demonstrated that the radiographic presence of osteophytes is both sensitive and specific to hip OA [9] but the physical examination is more sensitive and specific than X-ray for diagnosing symptomatic hand OA [9] . However, the EULAR recommends plain radiographs as the gold standard for morphological assessment of hand OA. A posteroanterior radiograph of both hands on a single film/field of view is adequate for diagnosis [23] . In clinical practice, if a patient presents with an abrupt onset of IP joint pain and functional loss with inflammatory symptoms, performing a hand X-ray for assessing erosive OA may be of help in confirming the diagnosis [23] .
MRI in the diagnosis of OA
MRI offers superb soft tissue contrast in a tomographic presentation and has the advantage over X-ray or US in visualizing all the structures within a joint (Fig. 2) . MRI detection of synovitis is improved with i.v. contrast by enabling differentiation from joint effusion [24] . However, such contrast agents require i.v. access and have small risks of allergic reactions and are associated with rare side effects such as nephrogenic fibrosis [25] . Spin echo (SE) and fast SE (FSE) imaging techniques are useful in evaluating focal cartilage defects. Recent improvements in hardware, software, gradients and radiofrequency coils have led to the use of fast or turbo SE imaging, fat saturation and water excitation to improve tissue contrast [26] . In addition, morphological assessment of cartilage using 3D spoiled gradient recalled echo imaging with fat suppression or T1/T2 rho mapping provides information about tissue size and structural integrity [27, 28] . When specific sequences are needed, it is worth involving a radiologist.
In studies that compared MRI findings with clinical examination in knee OA, one noted that using MRI did not increase the diagnostic accuracy of OA if clinical features of OA were present prior to imaging [29] . Another reported no consistent association between clinical assessment and MRI abnormalities other than for joint effusion [30] . In an older population with no radiographic evidence of knee OA, 89% had MRI changes compatible with symptoms. The presence of at least one type of pathology was high in both painful (up to 97%) and painless (up to 88%) knees [10] . For this reason, in clinical practice an MRI scan should be requested only to answer a specific question in an OA case. For example, detecting a meniscal tear may warrant surgical referral in a patient who reports true locking of the knee joint (as opposed to complaints of pseudo-locking or gelling). Single MRI features in early knee OA have an insufficient discriminative power to be a predictor of future OA, but combined MRI features in a prediction model have the potential to identify radiographic OA in 5 years (sensitivity 66%, specificity 67%) [31] . A full history, clinical examination and anteroposterior X-ray of the affected hip should be the first-line choice of imaging to diagnose the cause of hip pain, but MRI has a definite role in excluding or confirming differential diagnoses, such as osteonecrosis, avascular necrosis and insufficiency fracture. MRI arthrography may have a specific role to help diagnose a labral tear, for which it is the firstline imaging of choice [32] , or in the differential diagnosis of femoroacetabular impingement [33] .
A recent study in patients with long-standing erosive hand OA found no statistical associations between radiographs and MRI with regard to the detection of JSN, malalignment and bone erosions [34] . It also reported that synovitis was detected in 39.8% of the joints (in a mild form in 80%), erosions were found in 51.1% and BMLs were identified in 20.5 and 23.9% at the distal and proximal sides, respectively [34] . MRI-detected synovitis, BMLs and erosions were all associated with clinical joint tenderness [35, 36] . While the literature on the use of MRI to assess hand OA is slowly growing, it remains a research tool at present, providing a greater understanding of structurepain relationships and giving insights into the progression of structural changes [37] .
US in the diagnosis of OA
US is a highly sensitive modality, whereas the use of highfrequency probes provides a resolution up to 0.1 mm. This modality uses sound waves, has no known side effects and offers the opportunity for scanning of multiple musculoskeletal regions in a single sitting [38] . In knee joint OA, sonography has shown its capability to detect and evaluate a wide spectrum of structural abnormalities involving the anterosuperior part of articular cartilage, bony cortex, synovial tissue and joint effusion. In comparison to radiography, US performed better or equally well in the identification of tibiofemoral osteophytes, medial meniscal extrusion and medial femoral cartilage morphological degeneration [39] . Ultrasonographic evaluations of knee medial meniscal bulging (extrusion), effusion and Baker's cyst were positively correlated with radiographic features and OA clinical symptoms [40, 41] . US has a moderate discriminative power between symptomatic and asymptomatic patients in most of the casecontrol studies that may aid in diagnosis [42] . It may be used as an educational tool for demonstrating relevant pathologies to patients when explaining symptoms. The major limitation of US in assessing OA is that only tissues superficial to bone may be examined; subchondral BMLs and cysts cannot be detected. In addition, US is viewed as an operator-dependent imaging technique. The intrinsic realtime nature of US image acquisition and interpretation could possibly result in a tendency to overdiagnose pathology [43] .
In hip OA, US scanning is conventionally limited to the anterior surface of the joint. Due to the depth of the hip joint, effusion cannot be detected by physical examination. However, with sonography, even a small intraarticular effusion of the hip joint can be detected by measuring the distance between the neck of the femur and the joint capsule [44] . A large joint effusion identified sonographically correlates well with radiographic findings of rapidly destructive hip OA [45] . Due to the limited acoustic window, US has limited accessibility to the hip joint space, but it is useful for analysing osteophytes [46] . In addition, osteophytes appear as cortical protrusions at the joint margin [47] , and choosing a lower-frequency linear or curvilinear probe for optimal penetration allows the visualization of deeper tissue [38] .
US may be helpful to demonstrate a pattern of erosive changes more characteristic of inflammatory arthritis, particularly in the hands, using the power Doppler technique (Fig. 3) [48, 49] . In patients with suspected or confirmed arthritis, when US was added to clinical findings, the diagnostic confidence in differentiating OA from inflammatory arthritis significantly increased [50] . In another study of erosive hand OA, more inflamed joints were detected using US in comparison with clinical examination [51] . Due to its multiplanar acquisition, US may also be useful for identifying osteophytes that may not be seen on X-rays [49] .
Other imaging modalities in the diagnosis of OA Like MRI, CT can offer 3D imaging of a joint compared with the traditional X-ray. CT has advantages over MRI of being cheaper, more widely available and having much faster scan acquisition times, but it does involve ionizing radiation [4] . When used to image peripheral joints, such as the hand or knee, the radiation dose is lower than the background annual radiation dose [52] . CT may have a role in confirming a diagnosis of hip OA if the clinical examination or X-ray are non-diagnostic, particularly as the inferoposterior and posterolateral hip joints frequently demonstrate osteophytes and loss of joint space and this region is not clearly visualized on a standard anteroposterior X-ray [53] . CT can demonstrate calcified cartilage [52] and may offer improved visualization of subchondral bone cysts and osteophytes compared with MRI or X-ray [54] .
A recent study confirmed the ability of SPECT to detect early knee OA with good correlation to clinical findings [55] . The potential advantages of PET depend on markers targeting specific tissues, of which bone remodelling and turnover in OA has been the primary endpoint to date. Kobayashi et al. [56] compared the diagnostic value of PET with MRI and radiography in early hip OA and found 96% concurrent findings between MRI and PET, with more joints having an increased PET signal than MRI measures in joints with mild or no radiographic OA. Nuclear imaging is limited by the use of radiopharmaceuticals with radiating isotopes and potential allergic reactions [4] . Its clinical application for OA is limited at present but may increase if specific radiopharmaceutical markers for cartilage are developed.
How can imaging inform the management of my patient with OA?
Modern imaging modalities have the capacity to visualize the whole joint, detect early structural abnormalities and measure changes over time. Numerous imaging studies have examined the use of quantitative and semi-quantitative measures, including effusion synovitis, meniscus pathology, cartilage morphology alteration and composition, BMLs, osteophytes and other markers, along with their correlations with clinically defined OA [47, 5760] . However, the increased information provided has not yet had any influence on clinical decision making with respect to non-surgical management. One randomized controlled trial (RCT) evaluating the impact of MRI on patients with knee pain in a general practice setting showed that access to MRI significantly increased general practitioners confidence in decision making but no changes in diagnosis or treatment plans [61] . A study in an orthopaedic setting investigating the impact of radiographs on management decisions in knee OA showed that radiographs led to alterations in management in 42% of cases [62] . This reflected a move away from arthroscopy and towards definitive surgery. A similar study in hip OA evaluating radiographic evidence in the priority assignment for surgery showed a significantly higher relative risk (RR 1.98) for an earlier assignment in patients with more severe radiographic scores [63] . Until now, no studies have evaluated the impact of imaging for the management of hand OA and no studies have specifically addressed the issue of non-surgical management.
Can imaging help in assessing disease progression and unexpected clinical deterioration?
Numerous longitudinal studies have reported the trajectories of changes in elementary lesions detected by imaging following OA natural history and described the parallel changes between abnormalities detected by different imaging modalities [64, 65] . For example, joint space width (JSW) or JSN were reported to be the most responsive radiographic measures to disease progression in knee [66, 67] , hip [68] and hand OA [69] . Radiographic changes can detect a change over long time periods but are often mild at the initial presentation and require specific measurements and reliable repeat positioning of the knee, which is not performed outside of the research setting [70] . For MRI cartilage morphometry in knee OA, there is some evidence for construct and predictive validity, with good evidence of reliability and responsiveness. The responsiveness of semi-quantitative MRI assessments of cartilage morphology, BMLs and synovitis was also good in knee OA [71] . Until now, the effectiveness of structure-modifying drugs remains elusive in OA [72] , hence, in clinical practice, serial imaging to monitor structural changes is not needed except to answer specific clinical questions. According to the recent EULAR recommendations, imaging is recommended if there is an unexpected rapid progression of symptoms or a change in clinical characteristics to determine whether this relates to OA severity or an additional diagnosis [22] .
Can imaging help in guiding intra-articular injections?
The added value of imaging to guide intra-articular injections, in particular the use of US, has been proposed in several knee studies. In two hyaluronic acid trials, the accuracy of injection guided by US has significantly increased (odds ratio 4.68) [73] and reached 96% when compared with blind injection [74] . There is only one study that has investigated fluoroscopically guided hyaluronic acid injection in the trapeziometacarpal joint, showing significant pain relief but no safety outcomes [75] . The accuracy of intra-articular injection depends on the joint and the skill of the practitioner, and imaging may improve accuracy [22] . Although accuracy was found to be better in imaging-guided injections compared with blind procedures, the results on the clinical outcomes of the injection were less consistent across studies. For these reasons, the systematic use of imaging for injections was not recommended, leaving this tool for specific situations identified by experts [63] . In addition, imaging is particularly recommended for joints that are difficult to access due to factors such as site (e.g. hip), degree of deformity and obesity. If injections are necessary, US guidance will result in accurate needle placement for aspiration and injection purposes [76] .
What is the value of imaging with respect to therapeutic response?
In clinical trials, imaging procedures are proposed when there is an intention to include/exclude participants with radiographic OA involvement of a specific joint or joint compartment. Imaging is also used to help identify subgroups/phenotypes of patients who are more or less likely to benefit from targeted intervention [77] . According to the Osteoarthritis Research Society InternationalUS Food and Drug Administration recommendations, radiographic JSW is still the recommended option for trials of structure modification [71] , with the understanding that the JSW construct represents a number of pathologies [78] and the trial duration may be long [71] . Furthermore, any cartilage defects, for example, in the non-weight-bearing portion of the posterior femur, will not affect the JSW seen on a plain film of the knee [79] .
MRI is now recommended for clinical trials in terms of cartilage morphometry assessment [80] . Quantitative cartilage assessments in the knee have been used reliably and responsively in OA clinical trials, but this technology is not ready for application in routine clinical practice, partly due to the time required for such assessments and partly because no disease-modifying drugs are available yet in practice that will slow or halt any detected cartilage loss [70] . Literature is also growing on MRI quantification (and its responsiveness) of other non-cartilage features [71] . Several MRI scoring systems that are used in longitudinal studies to describe pathological changes within the knee (MRI Osteoarthritis Knee Score) [81] , hand (Oslo Hand OA MRI score) [82] and hip (Hip Osteoarthritis MRI) [83] have now been applied as outcome measures in clinical trials [84] . Given the complexity of these semi-quantitative scores and their current lack of clinical utility (e.g. lack of evidence for the clinical importance of changes in any of the pathologies assessed) [71, 84] , they remain in the research setting only.
What is the use of imaging in diseasemodifying interventions?
While both US and MRI may be used to assess antiinflammatory (synovitis and osteitis) effects in RA, there are few studies that have assessed the response to antisynovial therapies in OA, most of which have failed to show a strong association between a change in synovitis and a change in pain [8587] . Although one open-label study using methotrexate for knee OA demonstrated a reduction in US-detected synovitis and pain [88] , a full RCT is needed to confirm the finding. The contrastenhanced dynamic MRIdetected synovial early enhancement rate has been shown to be responsive to intra-articular corticosteroids in knee OA [89] . Similarly, increased power Doppler signals have been reported to be associated with increased response to corticosteroids in hand OA [90] . In recent RCTs, quantitative synovial volume improved the predictive value of the current scoring systems and showed them to be more sensitive to changes [91, 92] . Since the underlying pathology of BMLs in painful OA is thought to increase bone resorption and remodelling, the inhibition of osteoclastic activity may reduce the size of BMLs, relieving OA symptoms [93] . This has been supported by a recent meta-analysis of bisphosphonates showing effective symptom relief in OA patients [94] . Among those trials that used MRI scans, one study demonstrated that a single infusion of bisphosphonates reduced BML size after 6 months of treatment [95] . Another trial of strontium ranelate reported protective effects on medial cartilage volume at 36 months in OA patients with co-localized meniscal extrusion and BMLs [96] .
Designed to interfere with specific targets, imaging has been used to find other novel therapies. RCTs of adalimumab, the first bioengineered fully humanized anti-TNF mAb, have reported no effects in hand OA [97, 98] , although a subgroup analysis found less erosive evolution on the radiographic images in patients with erosive hand OA and baseline soft tissue swelling [99] . Systematic reviews have revealed that anti-nerve growth factor therapy, including tanezumab, is efficacious in improving pain and function, but they also found serious adverse events, including rapidly progressive structural deterioration [100] . The use of imaging to evaluate safety has therefore taken on major importance [101] . Another analysis on the structural effects of sprifermin, a recombinant human fibroblast growth factor 18, found less worsening of cartilage damage and fewer BMLs, although no significant effects were seen in synovitis and osteophytes [102] . In two phase III trials, oral salmon calcitonin for 24 months did not affect radiographic JSN compared with placebo in patients with knee OA, but one study showed a significant difference in cartilage volume loss [103] .
Conclusion
Imaging offers a potential supplement to the clinical evaluation of patients with suspected OA. Selecting the correct imaging modality in the context of its advantages when visualizing a specific joint and with the clinical context in mind will enhance the added value of imaging in clinical practice. Radiography will continue to be a cornerstone in diagnosing OA when the clinical diagnosis remains uncertain, while MRI provides a more complete assessment of the joint and may be helpful in individuals with rapid disease progression or when symptoms cannot be explained by radiographic changes. US can offer rapid bedside assessment of peripheral joints and can easily assess dynamic inflammatory changes.
Although imaging modalities provide the capability to detect a wide range of joint pathologies, there is a need for methodologically robust studies to explore the added value of imaging in clinical diagnosis and management. Evidence of applying imaging in measuring therapy response that is of clinical benefit is still limited. Imaging may be used to identify patient subgroups and increase the likelihood of more effective treatments and responsive outcome measures.
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